David J. Andorsky, MD

About Dr. Andorsky

Dr. Andorsky is a board-certified medical oncologist and hematologist with extensive experience treating both solid tumors and blood cancers. His clinical focus includes breast, colorectal, lung, and genitourinary cancers, as well as hematologic malignancies such as leukemia, lymphoma, and multiple myeloma.

Dr. Andorsky is affiliated with the Sarah Cannon Research Institute, one of the world’s leading clinical research organizations dedicated to advancing cancer care. Through this partnership, he brings cutting-edge clinical trials and innovative therapies directly to patients at Rocky Mountain Cancer Centers (RMCC).

In addition to his research role, Dr. Andorsky serves as Associate Chair of US Oncology Hematology Research and is a principal investigator for numerous clinical trials at RMCC. He also sits on the RMCC Research Executive Committee and contributes to national cancer care standards as a member of the US Oncology Pathways Task Force.

Dr. Andorsky combines compassionate care with deep clinical expertise, ensuring his patients have access to the most advanced treatment options available today.